Drawing for QUANTUM CONTINUUM

USPTO serial 74564654

QUANTUM CONTINUUM

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
Examiner
LYKOS, ANGELA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with QUANTUM CONTINUUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042health care services, namely subacute health care administrative and management of patients in rehabilitative careABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 19, 1998EXPTEXPARTE APPEAL TERMINATED
Sep 16, 1997ABN3ABANDONMENT - AFTER EX PARTE APPEAL
Sep 16, 1997EXPAEX PARTE APPEAL-REFUSAL AFFIRMED
Oct 22, 1996CNESEXAMINERS STATEMENT MAILED
Aug 27, 1996EXPIEX PARTE APPEAL-INSTITUTED
Oct 17, 1995CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 10, 1995CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 1995CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 1995DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance